Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The model for the P1NP/CTX-1 ratio was significant (R2 = 0.287, p < 0.001); CV (per 1-percentage-point increase) was independently associated with the ratio (B = −0.00174, p = 0.017), and age (B = −0.0017, p = 0.041), BMI (B = −0.0069, p = 0.024), vitamin D (B = +0.00096, p = 0.020), PTH (B = +0.00074, p = 0.005), and insulin use (B = +0.0210, p = 0.033) were also significantly associated in the same model.

Source: 3. Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Because no prior pilot data were available for this specific biomarker panel, a conservative medium-to-large effect size (Cohen’s d = 0.63) was assumed; with a two-sided α of 0.05 and 80% power, at least 109 participants were required.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association Between Glycemic Variability and Bone Turnover and the Sema3A Signaling Pathway in Postmenopausal Women with Type 2 Diabetes Mellitus

Study design awaiting verification · Metabolites · 2026

Original publication title

Association Between Glycemic Variability and Bone Turnover and the Sema3A Signaling Pathway in Postmenopausal Women with Type 2 Diabetes Mellitus

Burcu Cosgun Bora; Sertas Erarslan

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: Highlights

What are the main findings?

  • Short-term glycemic variability was independently associated with bone turnover and circulating Sema3A-related biomarkers in postmenopausal women with T2DM, regardless of mean glycemia: the coefficient of variation (CV) with the bone formation/resorption balance (P1NP/CTX-1), and the daily peak-to-trough amplitude (Δ glucose) with NRP1 and the NRP1/PLXNA1 and SEMA3A/NRP1 ratios.

  • HbA1c-based glycemic control groups did not differ in bone turnover markers, Sema3A pathway components, or bone mineral density, whereas glycemic variability indices (SD, CV, Δ glucose) were consistently associated with these measures.

What are the implications of the main findings?

  • Assessing bone health in postmenopausal women with type 2 diabetes may require attention to short-term glycemic variability, not just average glycemic control, even when bone mineral density appears normal.

  • The NRP1/PLXNA1 and SEMA3A/NRP1 ratios are hypothesis-generating candidate biomarkers that warrant validation in longitudinal, multicenter studies before clinical application.

Source: Highlights Source: Highlights

Abstract: Abstract

Background:

This study evaluated relationships between glycemic variability, bone turnover markers, Sema3A pathway components, and bone mineral density in postmenopausal women with type 2 diabetes mellitus (T2DM).

Methods:

In this single-center cross-sectional study with prospective data collection, 126 postmenopausal women with T2DM performed capillary glucose measurements eight times daily for five days. Mean glucose, SD, CV, Δ glucose, and postprandial increment were calculated. Serum P1NP, CTX-1, SEMA3A, NRP1, and PLXNA1 were measured by ELISA, and P1NP/CTX-1, NRP1/PLXNA1, and SEMA3A/NRP1 ratios were derived. Bone mineral density was assessed by DXA. Associations were examined using Spearman correlation and multivariate regression adjusted for age, BMI, diabetes duration, vitamin D, PTH, insulin use, mean glucose, CV, and Δ glucose.

Results:

Bone turnover markers, Sema3A components, ratios, and T-scores did not differ across HbA1c-based groups (all p > 0.05). SD, CV, and Δ glucose correlated with several markers and ratios. CV was independently associated with P1NP/CTX-1 (B = −0.00174, p = 0.017); Δ glucose with NRP1 (B = −0.205, p = 0.013) and NRP1/PLXNA1 (B = −0.00023, p = 0.005); and both Δ glucose (B = 0.00035, p < 0.001) and mean glucose (B = −0.00022, p = 0.021) with SEMA3A/NRP1.

Conclusions:

Short-term glycemic variability, especially Δ glucose, was associated with bone turnover measures and exploratory Sema3A-related biomarkers independently of average glycemia; these associations may warrant consideration in future longitudinal studies of bone health in postmenopausal women with T2DM.

Source: Abstract
Authors’ abstract

Highlights

What are the main findings?

  • Short-term glycemic variability was independently associated with bone turnover and circulating Sema3A-related biomarkers in postmenopausal women with T2DM, regardless of mean glycemia: the coefficient of variation (CV) with the bone formation/resorption balance (P1NP/CTX-1), and the daily peak-to-trough amplitude (Δ glucose) with NRP1 and the NRP1/PLXNA1 and SEMA3A/NRP1 ratios.

  • HbA1c-based glycemic control groups did not differ in bone turnover markers, Sema3A pathway components, or bone mineral density, whereas glycemic variability indices (SD, CV, Δ glucose) were consistently associated with these measures.

What are the implications of the main findings?

  • Assessing bone health in postmenopausal women with type 2 diabetes may require attention to short-term glycemic variability, not just average glycemic control, even when bone mineral density appears normal.

  • The NRP1/PLXNA1 and SEMA3A/NRP1 ratios are hypothesis-generating candidate biomarkers that warrant validation in longitudinal, multicenter studies before clinical application.

Abstract

Background:

This study evaluated relationships between glycemic variability, bone turnover markers, Sema3A pathway components, and bone mineral density in postmenopausal women with type 2 diabetes mellitus (T2DM).

Methods:

In this single-center cross-sectional study with prospective data collection, 126 postmenopausal women with T2DM performed capillary glucose measurements eight times daily for five days. Mean glucose, SD, CV, Δ glucose, and postprandial increment were calculated. Serum P1NP, CTX-1, SEMA3A, NRP1, and PLXNA1 were measured by ELISA, and P1NP/CTX-1, NRP1/PLXNA1, and SEMA3A/NRP1 ratios were derived. Bone mineral density was assessed by DXA. Associations were examined using Spearman correlation and multivariate regression adjusted for age, BMI, diabetes duration, vitamin D, PTH, insulin use, mean glucose, CV, and Δ glucose.

Results:

Bone turnover markers, Sema3A components, ratios, and T-scores did not differ across HbA1c-based groups (all p > 0.05). SD, CV, and Δ glucose correlated with several markers and ratios. CV was independently associated with P1NP/CTX-1 (B = −0.00174, p = 0.017); Δ glucose with NRP1 (B = −0.205, p = 0.013) and NRP1/PLXNA1 (B = −0.00023, p = 0.005); and both Δ glucose (B = 0.00035, p < 0.001) and mean glucose (B = −0.00022, p = 0.021) with SEMA3A/NRP1.

Conclusions:

Short-term glycemic variability, especially Δ glucose, was associated with bone turnover measures and exploratory Sema3A-related biomarkers independently of average glycemia; these associations may warrant consideration in future longitudinal studies of bone health in postmenopausal women with T2DM.

Publication and source details

Original title: Association Between Glycemic Variability and Bone Turnover and the Sema3A Signaling Pathway in Postmenopausal Women with Type 2 Diabetes Mellitus

Burcu Cosgun Bora; Sertas Erarslan

Metabolites · 2026

* Correspondence: sertas.erarslan@ksbu.edu.tr; Tel.: +90-533-3858281© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Scientific Research Projects Coordination Unit of Kütahya Health Sciences Universityhttps://ror.org/01fxqs415 TTU-2025-274This research was supported by the Scientific Research Projects Coordination Unit of Kütahya Health Sciences University under project number TTU-2025-274. The funder had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:38:10.086716+00:00

DOI: 10.3390/metabo16100723 · PMC13706936